Table 2 Physiochemical properties.
From: Predicting bone cancer drugs properties through topological indices and machine learning
Graphs | Drug | BP | EV | FP | MR | SA | P | ST | MV |
|---|---|---|---|---|---|---|---|---|---|
\(G_{0}\) | ActinomycinD | 1386 | 211.5 | 792.1 | 323.7 | 356 | 128.3 | 53.9 | 880.7 |
\(G_{1}\) | Anastrozole | 469.7 | 73.2 | 237.9 | 90 | 78 | 35.7 | 42.2 | 270.3 |
\(G_{2}\) | Cabozantinib | 758.1 | 110.4 | 412.3 | 137 | 99 | 54.3 | 67.5 | 359 |
\(G_{3}\) | Cyclophosphamide | 336.1 | 57.9 | 157.1 | 58.1 | 51 | 23 | 44.3 | 195.3 |
\(G_{4}\) | Doxorubicin | 810.3 | 123.5 | 443.8 | 131.5 | 206 | 52.1 | 96.4 | 336.6 |
\(G_{5}\) | Etoposide | 798.1 | 121.7 | 263.6 | 140.1 | 161 | 55.5 | 76.5 | 378.5 |
\(G_{6}\) | Gemcitabine | 482.7 | 86.2 | 245.7 | 52.1 | 108 | 20.6 | 65.3 | 142.3 |
\(G_{7}\) | Ibandronate | 587.8 | 100.7 | 309.3 | 68.9 | 158 | 27.3 | 70.8 | 220.2 |
\(G_{8}\) | Ifosfamide | 336.1 | 57.9 | 157.1 | 58.1 | 51 | 23 | 44.3 | 195.7 |
\(G_{9}\) | Letrozole | 563.5 | 84.7 | 294.6 | 87.1 | 78 | 34.5 | 53.5 | 234.5 |
\(G_{10}\) | Pazopanib | 728.8 | 106.4 | 394.6 | 120.2 | 127 | 47.6 | 56.7 | 310.4 |
\(G_{11}\) | Regorafenib | 513.4 | 78.5 | 264.3 | 113.1 | 92 | 44.8 | 50.8 | 323.7 |
\(G_{12}\) | Sorafenib | 523.3 | 79.7 | 270.3 | 113.1 | 92 | 44.8 | 51.8 | 319.5 |
\(G_{13}\) | Tamoxifen | 482.3 | 74.7 | 140 | 118.9 | 12 | 47.1 | 40.4 | 356.2 |
\(G_{14}\) | Zoledronicacid | 764 | 116.7 | 415.8 | 50.3 | 173 | 19.9 | 149.7 | 127.4 |
